Pavilion Capital

Tracked participation in 2 Atlas companies, with 0 explicitly attributed leads.

2portfolio companies

7round participations

0lead positions

Jan 2024latest activity

Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleAttributed partner

RRebellionsChipsRebellions is a chip and software company focused on AI inference infrastructure—building purpose-engineered neural…$2.3Bvaluation$1.1BraisedRecent roundsPre-IPO funding round · Mar 2026$400M · led by Korea National Growth Fund, Mirae Asset Financial GroupSeries C (final close / expansion) · Nov 2025$250M · Kindred Ventures, Top Tier Capital PartnersSeries C · Sep 2025$250M · Arm, Korea Development Bank +5Rebellions$283MJun 2022 → Jan 20243 roundsParticipant—

IMInsilico Medicine—Sep 2017 → Jun 20224 roundsParticipant—

DateCompanyRoundRaisedValuationRoleEvidence

Jan 30, 2024RRebellionsChipsRebellions is a chip and software company focused on AI inference infrastructure—building purpose-engineered neural…$2.3Bvaluation$1.1BraisedRecent roundsPre-IPO funding round · Mar 2026$400M · led by Korea National Growth Fund, Mirae Asset Financial GroupSeries C (final close / expansion) · Nov 2025$250M · Kindred Ventures, Top Tier Capital PartnersSeries C · Sep 2025$250M · Arm, Korea Development Bank +5RebellionsSeries B$124M—Participant

Source ↗

Jul 05, 2022RRebellionsChipsRebellions is a chip and software company focused on AI inference infrastructure—building purpose-engineered neural…$2.3Bvaluation$1.1BraisedRecent roundsPre-IPO funding round · Mar 2026$400M · led by Korea National Growth Fund, Mirae Asset Financial GroupSeries C (final close / expansion) · Nov 2025$250M · Kindred Ventures, Top Tier Capital PartnersSeries C · Sep 2025$250M · Arm, Korea Development Bank +5RebellionsSeries A extension$22.8M—Participant

Source ↗

Jun 06, 2022IMInsilico MedicineSeries D$60M—Participant

Source ↗

Jun 02, 2022RRebellionsChipsRebellions is a chip and software company focused on AI inference infrastructure—building purpose-engineered neural…$2.3Bvaluation$1.1BraisedRecent roundsPre-IPO funding round · Mar 2026$400M · led by Korea National Growth Fund, Mirae Asset Financial GroupSeries C (final close / expansion) · Nov 2025$250M · Kindred Ventures, Top Tier Capital PartnersSeries C · Sep 2025$250M · Arm, Korea Development Bank +5RebellionsSeries A$50M$283MParticipant

Source ↗

Jun 22, 2021IMInsilico MedicineSeries C$255M—Participant

Source ↗

Sep 12, 2019IMInsilico MedicineSeries B$37M—Participant

Source ↗

Sep 10, 2017IMInsilico MedicineSeries B$37M—Participant

Source ↗

DateCompanyRoundRaisedValuationRoleEvidence

Jun 22, 2021IMInsilico MedicineSeries C$255M—Participant

Source ↗

Jun 06, 2022IMInsilico MedicineSeries D$60M—Participant

Source ↗

Sep 12, 2019IMInsilico MedicineSeries B$37M—Participant

Source ↗

Sep 10, 2017IMInsilico MedicineSeries B$37M—Participant

Source ↗